Important Information for Educated Investors

The "EDUCATED INVESTOR"
This web site (document) contains forward-looking statements that are subject to risks and uncertainties, including, but not limited to, certain delays beyond Symbollon's control with respect to future business events, regulatory approvals and other risks detailed from time to time in the company’s filings with the Securities and Exchange Commission (SEC). This material discusses Symbollon's drugs and technologies which are not yet available for commercial distribution. The safety, efficacy and risks of these drug products are being evaluated in research, pre-clinical trials and human clinical trials.

There are "ups" and "downs" in practically every business and stock. Although there are no guarantees about the stock market or Symbollon stock, before you invest in any security, you can help protect yourself by being an educated investor. If you are interested in Symbollon stock, we recommend that, at a minimum, you read our latest annual report and 10-K, 10-Q and 8-K report to the SEC. Our recent proxy statement for our shareholder meeting also contains important information. It is also advisable to learn more about Symbollon and our industry through a variety of public materials.

Our recent annual reports, 10-K and 10-Q reports and other materials will be accessible through this web site. Other materials we have filed with the SEC are available through its web site at "Edgar". You can also visit the SEC at its Washington or various regional offices for the same information.

CAUTIONARY INSTRUCTIONS REGARDING "FORWARD-LOOKING STATEMENTS"
Materials in this website may contain information that includes or is based upon forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements give our expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. They use words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results.

Any or all of our forward-looking statements here or in other publications may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed. Actual results may vary materially, and there are no guarantees about the performance of Symbollon stock.

We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports to the SEC.

Any links that we may provide to other Web sites are provided as a courtesy. By clicking these links, the user acknowledges that he/she is leaving the Symbollon website and Symbollon's disclaimer no longer applies. You are solely responsible for your interactions on any other Web site that you visit and Symbollon is not responsible for any content on any of the Web sites to which links are provided.

Any links that we may provide to other Web sites are provided as a courtesy. By clicking these links, the user acknowledges that he/she is leaving the Symbollon website and Symbollon's disclaimer no longer applies. You are solely responsible for your interactions on any other Web site that you visit and Symbollon is not responsible for any content on any of the Web sites to which links are provided.